John D. Fraser
Auckland, AUK, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Refinement of a novel staphylococcal superantigen-like poly protein vaccine.
Journal: Vaccine
Published: April 16, 2025
Feasibility of using a combination of staphylococcal superantigen-like proteins 3, 7 and 11 in a fusion vaccine for Staphylococcus aureus.
Journal: Immunology and cell biology
Published: January 31, 2024
Uncoupling Molecular Testing for SARS-CoV-2 From International Supply Chains.
Journal: Frontiers in public health
Published: November 03, 2021
Enterotoxins can support CAR T cells against solid tumors.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 27, 2019
Impact of Superantigen-Producing Bacteria on T Cells from Tonsillar Hyperplasia.
Journal: Pathogens (Basel, Switzerland)
Published: May 08, 2019
Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics.
Journal: Nature genetics
Published: May 16, 2018
Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: March 15, 2018
Development of an opsonophagocytic killing assay for group a streptococcus.
Journal: Vaccine
Published: March 01, 2018
Staphylococcal enterotoxin-like X (SElX) is a unique superantigen with functional features of two major families of staphylococcal virulence factors.
Journal: PLoS pathogens
Published: April 08, 2017
A potential role for staphylococcal and streptococcal superantigens in driving skewing of TCR Vβ subsets in tonsillar hyperplasia.
Journal: Medical microbiology and immunology
Published: March 20, 2017
Clinical development strategy for a candidate group A streptococcal vaccine.
Journal: Vaccine
Published: December 21, 2016
Last Updated: 09/26/2026